A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT06256549 · UNKNOWN
Trial details
- NCT number
- NCT06256549
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-09
- Primary completion
- 2024-07-20
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.